Cell Therapeutics, Inc.

Seattle, WA 98119

SBIR Award Summary

Total Number of Awards 3
Total Value of Awards $225K
First Award Date 09/30/96
Most Recent Award Date 04/02/00

Key Personnel

Last Name Name Awards Contact
Klaus Stephen J Klaus 2
Singer Jack W Singer 1

3 Awards Won

Phase 2 STTR

Agency: Department of Health & Human Services
Topic:
Budget: 04/02/00 - 04/01/01

DESCRIPTION: (Adapted from the applicant's abstract) The goal of these studies is to develop an orally bioavailable compound for the treatment of multiple sclerosis (MS), by defining the pharmacophore of a novel anti-inflammatory compound termed Lisofylline (LSF). MS is a T cell mediated, demyelinating autoimm...

Phase 2 STTR

Agency: Department of Health & Human Services
Topic:
Budget: 04/02/99 - 04/01/00

DESCRIPTION: (Adapted from the applicant's abstract) The goal of these studies is to develop an orally bioavailable compound for the treatment of multiple sclerosis (MS), by defining the pharmacophore of a novel anti-inflammatory compound termed Lisofylline (LSF). MS is a T cell mediated, demyelinating autoimm...

Phase 1 STTR

Agency: Department of Health & Human Services
Topic:
Budget: 09/30/96 - 02/28/98